Evidence map›Paper›PMID 37815117›Full record

ArticleNanomedicine (London, England)2023

Lipid nanocarrier targeting activated macrophages for antiretroviral therapy of HIV reservoir.

Di Wu, Mengjie Si, Hui Yi Xue, Ngoc T Tran, Kamel Khalili, Rafal Kaminski, Ho Lun Wong

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomedicine (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Di WuSchool of Pharmacy, Temple University, 3307 North Broad Street, Philadelphia, PA 19140, USA.
Mengjie SiSchool of Pharmacy, Temple University, 3307 North Broad Street, Philadelphia, PA 19140, USA.
Hui Yi XueSchool of Pharmacy, Temple University, 3307 North Broad Street, Philadelphia, PA 19140, USA.
Ngoc T TranSchool of Pharmacy, Temple University, 3307 North Broad Street, Philadelphia, PA 19140, USA.
Kamel KhaliliLewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Rafal KaminskiLewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Ho Lun WongSchool of Pharmacy, Temple University, 3307 North Broad Street, Philadelphia, PA 19140, USA.
Temple University · US

Funding

Viral Gene Editing and Bioinformatics Core for Institution # 269291P30MH092177 · NIMH · TEMPLE UNIV OF THE COMMONWEALTH · PI Brian Wigdahl · 2011 to 2026
$24.9M
New nanotechnology to enhance brain-delivery of antiretroviral drugs for treatment of HIV-associated neurocognitive disorderR03NS112078 · NINDS · TEMPLE UNIV OF THE COMMONWEALTH · PI WONG, HO-LUN · 2019 to 2020
$159k
NIH HHS R03NS112078NIMH NIH HHS P30 MH092177NINDS NIH HHS R03 NS112078
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-HIV AgentsHIV InfectionsAnti-Retroviral AgentsFolic AcidHumansLipidsMacrophagesRilpivirineAnti-HIV AgentsAnti-Retroviral AgentsFolic AcidLipidsRilpivirineantiretroviralHIVlipidlipid nano-antiretroviralsmacrophagenanoparticlesrilpivirine

Identifiers

PMID37815117
PMCPMC10652294
OpenAlexW4387472264

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.